RECRUITMENT IN ONTARIO IS NOW OPEN
Research on medications that reduce symptoms faster and prevent long COVID.
Research on medications that reduce symptoms faster and prevent long COVID.
The study is open to adults aged 18 – 49 years with one or more chronic condition(s) or adults aged 50+ years who tested positive for COVID with symptoms starting within the last five days.
About the study
Our goal is to identify effective, safe, affordable, and evidence-based medications so they can be accessed by the community
Reduce hospitalizations, reduce the burden on hospitals and ICUs, and help people have fewer symptoms and feel better faster
Open to Canadian residents (18+ years of age) who are within the first 5 days of experiencing COVID-19 symptoms
Directly influence standards of care for COVID-19 infection in community settings in Canada and around the world
Supported by $10 million in grants from the Canadian Institutes of Health Research, Health Canada and Public Health Agency of Canada
30+ partner organizations engaging diverse populations across Canada to evaluate the clinical- and cost-effectiveness of medications for COVID-19
Participate in our study.
Participate in our study
The CanTreatCOVID trial relies on volunteers, often referred to as participants, to help us better understand the effectiveness of medications for mild to moderate COVID-19. The study is open to adults aged 18 – 49 years with one or more chronic condition(s) or adults aged 50+ years who tested positive for COVID with symptoms starting within the last five days.
